1. Acknowledgement to Referees

   Acknowledgement to Referees 22 October 2021 Pages: 697 - 700

2. An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer

   • Yen-Shen Lu
   • Winnie Yeo
   • Rebecca Cheng

   Review Article Open access 28 September 2021 Pages: 701 - 741

3. Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis

   • Neil K. Mehta
   • Andraia R. Li
   • Terry A. Day

   Systematic Review 22 October 2021 Pages: 743 - 752

   

4. Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09

   • Akihito Tsuji
   • Masato Nakamura
   • Masashi Fujii

   Original Research Article 31 October 2021 Pages: 753 - 760

   

5. Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

   • Eliza A. Hawkes
   • Tycel Phillips
   • Stephen M. Ansell

   Original Research Article Open access 23 October 2021 Pages: 761 - 771

   

6. Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration

   • Siwen Hu-Lieskovan
   • Fadi Braiteh
   • Melissa L. Johnson

   Original Research Article Open access 25 October 2021 Pages: 773 - 787

   

7. Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)

   • Massimo Aglietta
   • Vanna Chiarion-Sileni
   • Paola Queirolo

   Original Research Article Open access 10 November 2021 Pages: 789 - 799

   

8. A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes

   • Christos Chouaid
   • Thomas Filleron
   • Xavier QUantin

   Original Research Article 18 October 2021 Pages: 801 - 811

   

9. Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy

   • Iris Y. Sheng
   • Shilpa Gupta
   • Alok A. Khorana

   Original Research Article 06 November 2021 Pages: 813 - 821

   

10. Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools

    • Fausto Castagnetti
    • Gianni Binotto
    • Massimiliano Bonifacio

    Therapy in Practice Open access 18 October 2021 Pages: 823 - 838

11. Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

    • Arnold Lee

    Adis Drug Evaluation Open access 11 October 2021 Pages: 839 - 845

    

12. Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer

    • Julia Paik

    Adis Drug Evaluation 08 October 2021 Pages: 847 - 856

    

13. Durvalumab: A Review in Extensive-Stage SCLC

    • Zaina T. Al-Salama

    Adis Drug Evaluation Open access 03 November 2021 Pages: 857 - 864

    

14. Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

    • Adam Brufsky
    • Xianchen Liu
    • Rachel M. Layman

    Correction 15 October 2021 Pages: 865 - 865

15. Correction to: Isatuximab: A Review of Its Use in Multiple Myeloma

    • James E. Frampton

    Correction Open access 08 October 2021 Pages: 867 - 867

16. Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

    • Yvette N. Lamb

    Correction Open access 25 October 2021 Pages: 869 - 869